Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Up 970-Fold Since Its IPO, Amgen Stock Could Be Overvalued

Forbes - 14 Aug 2023 16:37
Up 970-Fold Since Its IPO, Amgen Stock Could Be Overvalued Amgen's established products declined while some of its best-selling drugs enjoyed growth.
Full Article at Forbes

More Market News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard